1. Home
  2. CPIX vs PYXS Comparison

CPIX vs PYXS Comparison

Compare CPIX & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.08

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

N/A

Current Price

$1.56

Market Cap

71.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
PYXS
Founded
1999
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
71.6M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
CPIX
PYXS
Price
$3.08
$1.56
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
137.3K
296.1K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.70
28.65
EPS
N/A
N/A
Revenue
$42,010,949.00
$16,146,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$0.84
52 Week High
$6.27
$5.55

Technical Indicators

Market Signals
Indicator
CPIX
PYXS
Relative Strength Index (RSI) 33.13 52.16
Support Level $2.78 $1.27
Resistance Level $3.80 $1.69
Average True Range (ATR) 0.31 0.09
MACD -0.13 0.03
Stochastic Oscillator 3.00 78.57

Price Performance

Historical Comparison
CPIX
PYXS

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: